4.6 Article

Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph+ ALL: A retrospective nationwide study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medicine, General & Internal

Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Robin Foa et al.

Summary: Current frontline therapy for Ph-positive acute lymphoblastic leukemia, which includes tyrosine kinase inhibitors, glucocorticoids, and blinatumomab, has significantly improved survival and achieved high-level clearance of measurable tumor cells.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Review Hematology

Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph+ ALL during both CR1 and CR2

Satoshi Nishiwaki et al.

Summary: The study analyzed data from 1625 adult patients with Ph+ ALL and found that patients with MRD- during CR1 had higher survival rates and lower relapse rates, while patients with MRD+ during CR2 had lower survival rates and higher relapse rates.

BLOOD ADVANCES (2021)

Article Hematology

Effects of Haplotype Matching on Outcomes after Adult Single-Cord Blood Transplantation

Junya Kanda et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)

Article Hematology

Impact of HLA Allele Mismatch at HLA-A, -B, -C, and-DRB1 in Single Cord Blood Transplantation

Hisayuki Yokoyama et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)

Article Medicine, General & Internal

Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

Robin Foa et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

Jae H. Park et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Biophysics

Cord blood transplantation: rewind to fast forward

A. Dahlberg et al.

BONE MARROW TRANSPLANTATION (2017)

Article Medicine, General & Internal

Cord-Blood Transplantation in Patients with Minimal Residual Disease

Filippo Milano et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Medicine, General & Internal

Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia

Hagop M. Kantarjian et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Hematology

HLA mismatching as a strategy to reduce relapse after alternative donor transplantation

Katharina Fleischhauer et al.

SEMINARS IN HEMATOLOGY (2016)

Article Hematology

Defining the Intensity of Conditioning Regimens: Working Definitions

Andrea Bacigalupo et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)